Ultime notizie per GSK (OTC:GLAXF) Azioni

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, antiviral, and vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.

GSK PLC

GSK ORD

BioNTech: Clinical Hold Removal Pushes ADC Development Program Forward

GSK's Q2 Success Amid Challenges: What Investors Need To Know

Moderna's Vaccine Progress Undermined By RSV Market Contraction (Rating Downgrade)

Gilead Sciences: Buy This Bargain Before It's Gone

Alumis: Recent IPO With Differentiated Data In Autoimmune Diseases

Ideaya Biosciences Advances Synthetic Lethality With IDE397 Success

Eliem Therapeutics: Recent Strategic Pipeline Restructuring

GSK: The Worst Is Finally Over (Rating Upgrade)

September CPI Inflation: Don't Be Lulled By False Comfort

Wave Life Sciences: Positive WVE-006 Data For AATD Leads To 2025 Catalyst

ABBV

ABUS

ALMS

AMGN

AZNCF

BIIB

BMYMP

BNTX

CGON

CVAC

ELYM

GILD

GLAXF

IDYA

INCY

MKGAF

MKKGY

MRNA

NONOF

NVAX

REGN

RHHBF

RHHBY

RHHVF

SNYNF

TEVA

TEVJF

TKPHF

Comments

GSK

Notizie

Ultime notizie per GSK (OTC:GLAXF) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO